[go: up one dir, main page]

MX2014005152A - Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient. - Google Patents

Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.

Info

Publication number
MX2014005152A
MX2014005152A MX2014005152A MX2014005152A MX2014005152A MX 2014005152 A MX2014005152 A MX 2014005152A MX 2014005152 A MX2014005152 A MX 2014005152A MX 2014005152 A MX2014005152 A MX 2014005152A MX 2014005152 A MX2014005152 A MX 2014005152A
Authority
MX
Mexico
Prior art keywords
allopathic
pain
treatment
pharmaceutical composition
tramadol hydrochloride
Prior art date
Application number
MX2014005152A
Other languages
Spanish (es)
Inventor
Oliver Daniel Walls Flores
Ramón Rodríguez Hernández
Eduardo Barrena Hernández
Original Assignee
Liomont S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54359444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014005152(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liomont S A De C V Lab filed Critical Liomont S A De C V Lab
Priority to MX2014005152A priority Critical patent/MX2014005152A/en
Priority to PCT/IB2015/053097 priority patent/WO2015166418A2/en
Publication of MX2014005152A publication Critical patent/MX2014005152A/en
Priority to CL2016002655A priority patent/CL2016002655A1/en
Priority to SV2016005308A priority patent/SV2016005308A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to an injectable pharmaceutical composition combining ketorolac tromethamine/tramadol hydrochloride, for the treatment of allopathic pain (moderate to severe), used as an analgesic, anti-inflammatory, fever reducer or antipyretic, using fewer excipients that do not contribute to the desired therapeutic effect.
MX2014005152A 2014-04-29 2014-04-29 Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient. MX2014005152A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MX2014005152A MX2014005152A (en) 2014-04-29 2014-04-29 Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.
PCT/IB2015/053097 WO2015166418A2 (en) 2014-04-29 2015-04-29 Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient
CL2016002655A CL2016002655A1 (en) 2014-04-29 2016-10-19 Pharmaceutical composition for the treatment of pain-related allopathies, using as active agent ketorolac tromethamine and tramadol hydrochloride
SV2016005308A SV2016005308A (en) 2014-04-29 2016-10-28 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALOPATHIES RELATED TO PAIN, USING AS ACTIVE AGENT TO KETOROLACO TROMETAMINE AND TRAMADOL CHLORHYDRATE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014005152A MX2014005152A (en) 2014-04-29 2014-04-29 Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.

Publications (1)

Publication Number Publication Date
MX2014005152A true MX2014005152A (en) 2015-10-28

Family

ID=54359444

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014005152A MX2014005152A (en) 2014-04-29 2014-04-29 Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.

Country Status (4)

Country Link
CL (1) CL2016002655A1 (en)
MX (1) MX2014005152A (en)
SV (1) SV2016005308A (en)
WO (1) WO2015166418A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019143234A1 (en) 2018-01-22 2019-07-25 AMÉZCUA AMÉZCUA, Federico Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019122982A1 (en) 2017-12-21 2019-06-27 Grünenthal GmbH Pharmaceutical combination in a bilayer tablet form comprising ketorolac tromethamine and tramadol hydrochloride, and its use in pain treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03012048A (en) * 2003-12-19 2005-06-23 Victor Guillermo Alvarez Ochoa Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain.
MX2010011193A (en) * 2010-10-12 2012-04-18 World Trade Imp Exp Wtie Ag Liquid pharmaceutical composition for pain treatment and prevention.
WO2013163142A1 (en) * 2012-04-25 2013-10-31 Yung Shin Pharm. Ind. Co., Ltd. Liquid pharmaceutical formulation containing ketorolac and tramadol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019143234A1 (en) 2018-01-22 2019-07-25 AMÉZCUA AMÉZCUA, Federico Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate

Also Published As

Publication number Publication date
WO2015166418A2 (en) 2015-11-05
CL2016002655A1 (en) 2017-02-17
WO2015166418A3 (en) 2016-01-07
SV2016005308A (en) 2017-05-15

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
ZA202308495B (en) Pharmaceutical compositions of therapeutically active compounds
PH12018502251A1 (en) Formulations of an lsd1 inhibitor
MY188139A (en) Sodium channel modulators for the treatment of pain
MX2021008113A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING AN IL-4R ANTAGONIST FOR USE IN THE TREATMENT OF ASTHMA.
PH12016501788A1 (en) Pharmaceutical compositions of therapeutically active compounds
EA201990424A1 (en) SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION
MX2018000419A (en) Substituted amide derivatives having multimodal activity against pain.
EA201990428A1 (en) SPIRALACTAM MODULERS OF NMDA RECEPTOR AND THEIR APPLICATION
EA201990425A1 (en) SPIRO-LACTAM AND BIS-SPIRO-LACTAM MODULATORS OF THE NMDA RECEPTOR AND THEIR APPLICATION
TW201613578A (en) Pharmaceutical combinations
PH12016502352A1 (en) Pharmaceutical composition
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2014005152A (en) Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.
MX2014005153A (en) Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain.
ZA201906153B (en) Pharmaceutical compositions for combination therapy
WO2019132729A3 (en) Indomethacin menthyl ester-based pharmaceutical compositions and use thereof
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
EA202090268A1 (en) CARBOXAMIDS AS SODIUM CHANNEL MODULATORS
MX2016012553A (en) Pharmaceutical compositions of mazindol with metformin for weight loss.
ZA201606135B (en) Pharmaceutical compositions of therapeutically active compounds
MX2015000473A (en) COMBINATION OF DOCOSAHEXAENOIC AND INDOMETACINE ACID FOR USE AS AN ANALGESIC.